Tradewinds Global Investors’s Teva Pharmaceuticals TEVA Stock Holding History

Tradewinds Global Investors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$2.77M	Sell	60,243 -956,727	-94%	-$49.9M	3.41%	10
2016 Q2	$51.1M	Sell	1,016,970 -39,456	-4%	-$2.1M	3.32%	6
2016 Q1	$56.5M	Buy	1,056,426 +152,224	+17%	+$8.93M	3.41%	3
2015 Q4	$59.4M	Sell	904,202 -99,428	-10%	-$6.14M	3.49%	4
2015 Q3	$56.7M	Sell	1,003,630 -486,747	-33%	-$31.6M	2.79%	5
2015 Q2	$88.1M	Sell	1,490,377 -354,088	-19%	-$21.8M	3.82%	2
2015 Q1	$115M	Sell	1,844,465 -290,097	-14%	-$16.9M	4.63%	3
2014 Q4	$123M	Sell	2,134,562 -151,473	-7%	-$8.44M	4.98%	1
2014 Q3	$123M	Sell	2,286,035 -62,894	-3%	-$3.33M	4.53%	1
2014 Q2	$123M	Sell	2,348,929 -132,176	-5%	-$6.76M	4.17%	1
2014 Q1	$131M	Sell	2,481,105 -416,142	-14%	-$19.2M	3.28%	2
2013 Q4	$116M	Buy	2,897,247 +502,432	+21%	+$19.8M	2.88%	3
2013 Q3	$90.5M	Sell	2,394,815 -1,184,059	-33%	-$46.2M	2.41%	5
2013 Q2	$140M	Buy	+3,578,874	New	+$139M	4.21%	1

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tradewinds Global Investors's TEVA Position: Q3 2016 in Review

Tradewinds Global Investors reduced its Teva Pharmaceuticals (TEVA) stake by 94% in Q3 2016, selling an estimated $49.9M and leaving 60,243 shares worth $2.77M. The position accounts for 3.41% of the portfolio, ranked #10.

Tradewinds Global Investors first reported a position in TEVA in Q2 2013 and has held it in 14 quarters since. The position peaked at $140M in Q2 2013. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Tradewinds Global Investors held 60,243 shares of Teva Pharmaceuticals worth $2.77M as of Q3 2016.
Tradewinds Global Investors sold 956,727 Teva Pharmaceuticals shares in Q3 2016, an estimated $49.9M.
Teva Pharmaceuticals made up 3.41% of Tradewinds Global Investors's portfolio in Q3 2016, its #10 holding.
Tradewinds Global Investors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
Tradewinds Global Investors's Teva Pharmaceuticals position peaked at $140M in Q2 2013.
795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Tradewinds Global Investors's 13F filing for Q3 2016, filed 14 Nov 2016.